CoChat

European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency

Open access

The DOI matches its Crossref record; 135 of the 149 references it cites were found in a registry or an index; 96 of the 172 sources its claims cite were checked for support.

Abstract

Glucocorticoids are widely prescribed as anti-inflammatory and immunosuppressive agents. This results in at least 1% of the population using chronic glucocorticoid therapy, being at risk for glucocorticoid-induced adrenal insufficiency. This risk is dependent on the dose, duration and potency of the glucocorticoid, route of administration, and individual susceptibility. Once glucocorticoid-induced adrenal insufficiency develops or is suspected, it necessitates careful education and management of affected patients. Tapering glucocorticoids can be challenging when symptoms of glucocorticoid withdrawal develop, which overlap with those of adrenal insufficiency. In general, tapering of glucocorticoids can be more rapidly within a supraphysiological range, followed by a slower taper when on physiological glucocorticoid dosing. The degree and persistence of HPA axis suppression after cessation of glucocorticoid therapy are dependent on overall exposure and recovery of adrenal function varies greatly amongst individuals. This first European Society of Endocrinology/Endocrine Society joint clinical practice guideline provides guidance on this clinically relevant condition to aid clinicians involved in the care of patients on chronic glucocorticoid therapy.

Overview

CoChat Summary

## TL;DR

This joint ESE/Endocrine Society guideline provides practical recommendations for evaluating, tapering, and treating adults at risk of glucocorticoid-induced adrenal insufficiency. It emphasizes that biochemical HPA-axis suppression is common, but clinically meaningful adrenal crisis is much rarer, so tapering and testing should be individualized.

## Key findings

  • Chronic glucocorticoid use is common: the paper states at least 1% of the population uses chronic glucocorticoid therapy and is therefore at risk for glucocorticoid-induced adrenal insufficiency.
  • In a meta-analysis, pooled biochemical adrenal insufficiency rates varied by route: 4.2% for nasal use, 48.7% for oral use, and 52.2% for intra-articular administration; in asthma, risk ranged from 1.4% after <28 days to 27.4% after >1 year, and from 2.4% at low dose to 21.5% at high dose.
  • For recovery of HPA axis function, pooled studies showed adrenal insufficiency decreased from 38.7% to 14.9% after 4 weeks in one group (141 patients) and from 56.4% to 25.3% after 6 months in another (174 patients). Across individual studies, recovery was reported in 58.8% (median 16 months), 60.6% (median 24 months), and 10% after 3 months.
  • For morning cortisol as a test of recovery, the guideline reports examples where >300 nmol/L (10 μg/dL) suggests HPA recovery, while <150 nmol/L (5 μg/dL) suggests persistent insufficiency; in included studies, values such as ≥336 nmol/L and >327 nmol/L had very high specificity/sensitivity for ruling in or out adrenal insufficiency.

## Methods

  • Joint clinical guideline developed by the European Society of Endocrinology and Endocrine Society using GRADE; recommendations were based on systematic literature searches plus expert panel consensus.
  • Literature searches were conducted in PubMed, MEDLINE, Embase, Web of Science, and Cochrane Library in January–March 2023; only adult studies and studies with ≥10 patients were eligible.
  • The evidence base included 3 studies for HPA-axis recovery, 5 studies for tapering strategy, and 3 studies for morning cortisol vs 250 μg ACTH (1-24)-test diagnostic accuracy.

## Limitations

  • The paper explicitly states that the evidence behind most recommendations is low or very low.
  • It also states that many findings are based on biochemical adrenal insufficiency, while the clinical relevance was often not established and outcomes such as adrenal crisis were not linked to test results.
  • Evident from the text: the included studies were small, heterogeneous, and often lacked head-to-head comparisons of tapering or diagnostic strategies, limiting firm conclusions.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/clinem/dgae250

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Schematic representation of HPA axis recovery following discontinuation of supraphysiologic glucocorticoid therapy (adapted from: Prete and Bancos 2021 (58)).
Figure 1. Schematic representation of HPA axis recovery following discontinuation of supraphysiologic glucocorticoid therapy (adapted from: Prete and Bancos 2021 (58)).CC BY-NC · PubMed Central
Figure 2. Proposed approach to systemic glucocorticoid discontinuation.
Figure 2. Proposed approach to systemic glucocorticoid discontinuation.CC BY-NC · PubMed Central
Figure 3. Management of patients at risk of or with diagnosed glucocorticoid-induced adrenal insufficiency with suspected adrenal crisis or during exposure to stress.
Figure 3. Management of patients at risk of or with diagnosed glucocorticoid-induced adrenal insufficiency with suspected adrenal crisis or during exposure to stress.CC BY-NC · PubMed Central

Verification

Claims the paper makes

66 Valid · 13 Not valid · 36 Not checked · 66 Own results and interpretations

99 more claims · 38 with their cited sources checked

Create a free account to see all 181 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 32
  • It may state two separate claims as one. 54
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 135 references

Research works printed but not linked: 1

  1. Nicolaides, 2000, Endotext

Cited by

See all 172

Metadata

Authors
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., Yedinak, C., & Dekkers, O. M.
Affiliations
  • University of Zurich (CH)
  • University of Michigan (US)
  • Mayo Clinic (US)
  • University of Würzburg (DE)
  • The University of Texas Southwestern Medical Center (US)
  • Leiden University Medical Center (NL)
  • Haukeland University Hospital (NO)
  • University Hospitals Birmingham NHS Foundation Trust (GB)
  • Brigham and Women's Hospital (US)
  • Oregon Health & Science University (US)
  • Aarhus University (DK)
Corresponding author
Beuschlein, Felix
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2024-05-10
Volume
109
Issue
7
Pages
1657-1683
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W4396810892
Cited by
172
References
149
Citations by year
2026: 103 · 2025: 55 · 2024: 13
FWCI
47.27
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by-nc)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Leiden Repository (Leiden University) (submittedVersion, cc-by-nc)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
European Society of Endocrinology
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
glucocorticoid-induced adrenal insufficiency, chronic glucocorticoid therapy, glucocorticoid tapering, glucocorticoid withdrawal, HPA axis suppression, adrenal function recovery, diagnosis, treatment, individual susceptibility
MeSH terms
Adrenal Insufficiency, Endocrinology, Europe, Glucocorticoids, Humans, Societies, Medical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. https://app.cochat.ai/papers/10.1210/clinem/dgae250
The paper
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., Yedinak, C., & Dekkers, O. M. (2024). European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae250

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.